TUMOR INSTITUTE CCOP

肿瘤研究所 CCOP

• 批准号: 2712613
• 负责人: James Feusner
• 金额: $ 27.39万
• 依托单位: BAY AREA TUMOR INSTITUTE
• 依托单位国家: 美国
• 财政年份: 1993
• 资助国家: 美国
• 起止时间: 1993-06-25 至 2002-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/2712613
• 关键词: African American; Asian Americans; Hispanic Americans; adult human (21+); behavioral /social science research tag; cancer prevention; cancer rehabilitation /care; chemoprevention; child (0-11); clinical research; clinical trials; community health services; cooperative study; female; health services research tag; hospitals; human subject; human therapy evaluation; low socioeconomic status; medical outreach /case finding; neoplasm /cancer therapy; oncology; pediatric neoplasm /cancer; primary care physician

DESCRIPTION: (Applicant Description) The Bay Area Tumor Institute Community Clinical Oncology Program (BATI-CCOP) is a consortium of seven community and county hospitals in the Greater Oakland, California, area. Since its creation in 1979 as a CGOP and its conversion to CCOP status in 1989, this consortium has continuously provided the community's cancer specialists, primary care physicians, and hospitals with an NCI-approved and funded clinical trials program. Integrating the goals of DHHS publication "Healthy People 2000" by targeting minority, low income and female populations in Alameda County and its main city, Oakland, the BATI-CCOP enables cancer patients and the general "at risk" population to participate in therapeutic and cancer control research of SWOG, NSABP and CCG. Building on its achievements, the long-term objectives and specific aims of the BATI-CCOP include accrual to therapeutic trials at higher rates than comparable CCOP's, accrual of minority and pediatric patients at higher rates than all other CCOP's, aggressive cancer control recruitment and accrual exceeding NCI's cancer control requirements, increased interaction w i t h research bases, and continued fulfillment of NCI's "Terms of Cooperation". The CCOP will continue to accrue 100% of all eligible pediatric oncology patients in the region, 95% of all eligible cancer patients at the county hospital, and achieve minority and female participation that will exceed 75% of the total CCOP accrual. The CCOP will also continue to exceed NCI mandates and remain the Bay Area leader in accrual to cancer prevention and control trials. The BATI-CCOP offers a successful long-term track record, and organized and c o m mitted medical community, experienced physician investigators, institutional and financial support from the Bay Area Tumor Institute, and unusual access to African American, Hispanic, Asian, pediatric, underserved and female populations.

描述：（申请人描述）湾区肿瘤研究所社区 临床肿瘤学计划（BATI-CCOP）是一个由七个社区和 加州大奥克兰地区的县医院。 以来 1979年作为CGOP成立，1989年转为CCOP地位， 财团不断提供社区的癌症专家， 初级保健医生，以及获得NCI批准和资助的医院 临床试验项目。 结合卫生和公众服务部出版物《2000年健康人》的目标， 阿拉米达县的少数民族、低收入和女性人口及其主要 城市，奥克兰，BATI-CCOP使癌症患者和一般“在 参与治疗和癌症控制研究的“高危”人群 SWOG、NSABP和CCG。 在其成就的基础上， BATI-CCOP的目的和具体目标包括： 试验率高于可比CCOP、少数族裔的累积以及 儿童患者的发病率高于所有其他CCOP，侵袭性癌症 控制招募和累积超过NCI的癌症控制要求， 增加与研究基地的互动，并继续履行 NCI的“合作条款”。 CCOP将继续100%累积所有符合条件的儿科肿瘤 该地区95%的符合条件的癌症患者 医院，并实现少数民族和妇女参与率将超过75% CCOP应计总额的百分比。 CCOP也将继续超过NCI 授权并保持湾区在癌症预防方面的领先地位， 对照试验。 BATI-CCOP提供了一个成功的长期跟踪记录，并组织和 受认可的医学界，经验丰富的医生研究者， 湾区肿瘤研究所的机构和财政支持， 非裔美国人，西班牙裔，亚洲人，儿科，服务不足 和女性人口。